Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

SLNO holding history

Soleno Therapeutics Inc in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SLNO overviewAll 13F holders of SLNOFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of SLNO by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−242,262−100.0%Sold outHolders
Q1 2026242,262$8.11M<0.1%−45,377−15.8%ReducedHolders
Q4 2025287,639$13.3M<0.1%+121,794+73.4%AddedHolders
Q3 2025165,845$11.2M<0.1%−274,209−62.3%ReducedHolders
Q2 2025440,054$36.9M<0.1%+227,695+107.2%AddedHolders
Q1 2025212,359$15.2M<0.1%+2,122+1.0%AddedHolders
Q4 2024210,237$9.45M<0.1%+136,256+184.2%AddedHolders
Q3 202473,981$3.74M<0.1%−18,996−20.4%ReducedHolders
Q2 202492,977$3.79M<0.1%−11,026−10.6%ReducedHolders
Q1 2024104,003$4.45M<0.1%+53,316+105.2%AddedHolders
Q4 202350,687$2.04M<0.1%+17,587+53.1%AddedHolders
Q3 202333,100$976.8K<0.1%+33,100NewHolders
Q1 20230$00.0%−14−100.0%Sold outHolders
Q4 202214$28<0.1%−635−97.8%ReducedHolders
Q3 2022649$1.00K<0.1%+649NewHolders
Q2 20220$00.0%−43−100.0%Sold outHolders
Q1 202243$00.0%−279−86.6%ReducedHolders
Q4 2021322$00.0%−272−45.8%ReducedHolders
Q3 2021594$00.0%−10,059−94.4%ReducedHolders
Q2 202110,653$12.0K<0.1%+10,327+3,167.8%AddedHolders
Q1 2021326$00.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.